ABSTRACT
Introduction
The bacterial ribosome is one of the most common targets for antibiotics of clinical and veterinary relevance. Resistance to ribosome-targeting antibiotics occurs primarily through modification of drug's binding sites, specifically through mutation or modification of ribosomal RNA (rRNA) or ribosomal proteins 1 . Several rRNA modifying enzymes implicated in antibiotic resistance have been discovered 2 , and among them, the radical SAM enzyme Cfr is noteworthy because it provides cross-resistance to Phenicols (e.g. thiamphenicol), Lincosamides (e.g. clindamycin), Oxazolidinones (e.g. linezolid),
Pleuromutilins (e.g. tiamulin), and Streptogramin A (e.g. dalfopristin) through C8 methylation of the A2503 residue in 23S rRNA (E. coli numbering), which is located in the peptidyl transferase center (PTC) 3 . In addition to this so-called PhLOPSA phenotype 4 , Cfr-mediated methylation leads to resistance to 16-member macrolides, the aminocyclitol hygromycin A, and the nucleoside antimicrobial agent A201A [4] [5] [6] . cfr and cfr-like genes are typically found on mobile genetic elements (MGEs). Moreover, since acquisition of cfr exhibits low fitness costs 7 coli 13 . Equivalent functional evidence is missing for Cfr(C), though it has been shown to confer PhLOPS A resistance upon introduction into the linezolid-susceptible strain C. difficile 630Δerm 12 .
Linezolid is not used to treat C. difficile infections (CDI) despite its confirmed utility to prevent CDI in patients with ventilator associated pneumonia 14 and to reduce C. difficile toxin gut levels in a mice model 15 . Moreover, the closely related antibiotic cadazolid inhibits moxifloxacin-resistant C. difficile NAP1/027 strains without affecting gut commensals, 16 and though it did not pass a Phase III trial 17 , novel oxazolidinones to treat C. difficile infections may appear in the future. 
Methods

Strains
This study included ribotype-or PFGE-confirmed NAP1/027/ST01 clinical isolates from Mexico (DF11), Honduras (HON06, HON10, HON11) and Chile (PUC51, PUC347), and one isolate from the NAPCR1/012/ST54 genotype from Costa Rica (LIBA5707). These bacteria were recovered between determinations of minimum inhibitory concentrations (MIC) because it is a NAPCR1 strain that lacks cfrlike genes (see below) 18 .
MIC determinations
MIC of clindamycin and linezolid were obtained for isolates from México (DF), Honduras (HON) and Costa Rica (LIBA) using E-test strips containing a 0.16 to 256 µg/ml concentration gradient (BioMerieux). This isolate subset was also analyzed by agar microdilution 20 using brain heart infusion plates containing 1-256 µg/ml of tiamulin or thiamphenicol. The susceptibility of the Chilean isolates (PUC) to linezolid, tiamulin, and thiamphenicol was assessed using agar macrodilution with brain heart infusion plates containing 1-256 µg/ml of the corresponding antibiotics. C. difficile ATCC 70057
(linezolid s ) was tested in parallel for quality control purposes.
Comparative genomics
WGS were obtained by sequencing-by-synthesis using multiplexed paired-end libraries and Illumina HiSeq2000 or Miseq platforms. After trimming with sickle (https://github.com/najoshi/sickle), reads were assembled using Spades v.3.12 21 . For automated annotation we used Prokka v. 1.13 22 . Regions of interest were trimmed and reannotated using BLAST, BLASTP, eggNOG 23 and UniProt searches. 
Expression and purification of Cfr(C)
A codon optimized sequence of cfr(C) was cloned into the pET21a vector and overexpressed in Escherichia coli BL21-CodonPlus (DE3)-RIPL as described previously 26, 30, 31 . The resulting enzyme was then purified by Talon chromatography (Clontech) and underwent iron-sulfur cluster reconstitution using previously published protocols 26, 30, 31 .
Preparation of truncated rRNA substrates for the in vitro methylation assay
The E. coli 23S rRNA fragment 2447-2625 used in the in vitro methylation assay (see below) was generated by in vitro transcription following a previously published protocol 26, 30 . C. difficile 23S rRNA fragments 2451-2629 and 2022-2629 were generated by in vitro transcription in the same manner but using different PCR products as templates. Briefly, forward PCR primers contained the T7 RNA polymerase promoter sequence TAATACGACTCACTATAGG, followed by several nucleotides corresponding to specific region of C. difficile 23S rRNA. 23S rRNA fragments were amplified using genomic C. difficile DNA purchased from the American Type Culture Collection as template.
In vitro methylation assay
In vitro reactions were performed in 100 µL volumes under the following conditions: 100 mM HEPES pH and 0.14 μCi [14C-methyl]-SAM (58 mCi/mmoL) and 5-10 μM purified enzyme. Reactions were initiated by addition of 1 mM NADPH (final concentration) and were allowed to proceed at 37°C for 1.5 h. The RNA was recovered from the reaction mixtures using the RNA Clean & Concentrator kit (Zymo Research) and added to vials containing Ultima Gold scintillation fluid (Perkin Elmer). The amount of radioactivity incorporated in the product was measured using a Beckman-Coulter LS6500 multipurpose scintillation counter (Fullerton, CA, USA). Each value represents the average of at least duplicate measurements, with one standard deviation (SD) indicated.
HPLC separation and identification of methylated adenosines
Purified, methylated rRNA from in vitro reactions was enzymatically digested to mononucleosides using nuclease P1 (Sigma-Aldrich), snake venom phosphodiesterase (Sigma-Aldrich), and alkaline phosphatase from calf intestine (New England Biolabs) as described before 26, 30 . The digested samples were separated by HPLC using a Luna analytical C18 column (10 μm, 4.6 mm × 250 mm) (Phenomenex, Torrance, CA, USA) and a previously published protocol 26, 30 . Mononucleosides and synthetic methyladenosine standards were detected by their UV absorption at 256 nm, while the 14 Clabeled methyladenosines were detected with a Packard radiomatic 515TR flow scintillation analyzer (Perkin Elmer).
Results
Detection of cfr -like genes
Isolates HON06, HON11, PUC51, and PUC347 carry a cfr(B) gene identical to that of C. difficile 11140508 (Table 1) . On the other hand, isolates HON10 and LIBA5707 have the cfr(C) allele previously seen in C. difficile T10 (Table 1) All cfr-like genes detected were found on four types of putative MGEs with anticipated mobilization or conjugation potential (Table 2 ). In detail, while isolates HON06 and HON11 have cfr(B) within a Tn6218-like element, isolates PUC51 and PUC347 have cfr(B) elsewhere in their genomes in an undescribed genetic structure ( Table 2 ). The best hit for this novel MGE in a megablast search against the nr database was a genomic fragment of Faecalibacterium prausnitzii L2/6 (Query cover=74%, Evalue=0, Identity=99%); a species that has not been previously reported to carry cfr-like genes. The cfr(C) genes of isolates HON10 and LIBA5707, in turn, were traced back to a MGE sharing similarity with the ICEs of C. difficile F548
12
( Table 2 ). The putative new cfr-like gene of isolate DF11 was found integrated into a distinct MGE that shows partial hits to genomic sequences of various intestinal Firmicutes (Table 2) , including Lachnoclostridium sp. YL32 (Query cover=60%, E-value=0, Identity=94%), Roseburia intestinalis XB6B4 (Query cover=60%, Evalue=0, Identity=92%), Faecalibacterium prausnitzii A2165 (Query cover=60%, Evalue=0, Identity=88%), and C. difficile Z31 (Query cover=60%, Evalue=0, Identity=87%). In this case, the shared regions were concentrated at the 5´and 3´ ends of the element and did not include the putative cfr-like gene or their immediate neighboring genes ( Table 2) . None of the WGS studied showed mutations or indels in 23S RNA genes, the ribosomal proteins L3 and L4, or presence of OptrA, which are mechanisms known to lead to a PhLOPSA phenotype.
MIC
To evaluate whether the presence of cfr-like genes in clinical isolates leads to PhLOPSA phenotype we performed susceptibility tests to several PTC-targeting antibiotics. As a negative control we used NAPCR1 strain LIBA5701, which lacks cfr-like genes and thus does not exhibit PhLOPSA phenotype (Table 3) . Isolates HON06 and HON11, which carry cfr(B) in a Tn6218-like context, and HON10 and LIBA5707, which is positive for cfr(C), exhibited an 8-24 fold increase in the MIC of linezolid and ≥128 fold increase in the MIC of tiamulin with respect to the control strain (Table 3) . In a comparable manner, (Table 3 ). All isolates had a MIC for clindamycin ≥256 µg/mL due to presence of the methylase ErmB ( 18, 19 , unpublished data). Despite carrying a cfr(B) gene, the MICs of linezolid, tiamulin, and thiamphenicol obtained for the Chilean isolates PUC51 and PUC347 were at least 2-4 fold lower than those obtained for the other test isolates, yet MIC of linezolid and tiamulin were still at least 12 fold higher than the MIC obtained for the LIBA5701 control (Table 3 ).
Functional analysis of Cfr(C)
To investigate whether Cfr(C) is a C8-methylating enzyme, we overexpressed in Escherichia coli a codon-optimized version of the cfr(C) sequence of HON10/LIBA5707. The resulting protein was purified under anaerobic conditions and its iron-sulfur cluster reconstituted. Thereafter, we performed an in vitro methylation assay with either in vitro transcribed 23S rRNA E. coli or C. difficile fragments and [ To establish the regioselectivity of the modification on the adenosine ring by Cfr(C), radiolabeled RNA product isolated from the in vitro assay with E. coli RNA was purified, digested to individual nucleosides, We provide for the first-time in vitro evidence of the RNA methylation activity of Cfr(C). Combined with the observation of a PhLOPSA phenotype in isolate DF11, the clustering of this novel putative cfr-like sequence with Cfr(C) suggests that its product could be a Cfr methylating enzyme implicated in antibiotic resistance. This hypothesis is yet to be experimentally verified.
The finding of cfr-like genes in various types of MGEs with partial hits to genomic sequences reported for other intestinal Firmicutes lends evidence for the plasticity of the C. difficile genome 32 and supports the role of this pathogen as a reservoir of resistance genes in the human gut 33 . This situation is worrisome because linezolid is used for the treatment of methicillin-resistant Staphylococcus aureus 34 and vancomycin-resistant enterococci 35 , which reside in the same Phylum as clostridial organisms.
Indeed, versions of Tn6218, such as those detected in isolates HON06 and HON10, have been found among Enterococcus faecium isolates from German hospital patients 36 .
The widespread detection of cfr-like genes among various epidemic NAP1/RT027/ST01 strains deserves attention to clarify whether this situation contributes to virulence. This notion is reinforced by the fact that linezolid and moxifloxacin resistance, a marker of highly virulent C. difficile strains, are often linked in this ribotype 37 . Furthermore, since antibiotics are crucial both for the induction, progression, and treatment of CDI, multidrug-resistance (MDR) is particularly worrisome when present in epidemic types such as the NAP1/027/ST01 strain, which has been linked to severe disease and CDI 
